Sell Amylin Pharmaceuticals (AMLN) at the market. Read More
Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.
Analyst Articles
China’s central bank declined to raise short-term interest rates Monday setting off a wave of buying in equities and, more importantly, in commodities. Instead, the central bank increased its reserve requirements over the weekend. Read More
We added Ivanhoe Mines (IVN) after the copper & gold miner dropped sharply last week following an announcement that included changes in its relationship with itspartner Rio Tinto in the Oyu Tolgoi mine in Mongolia. But the key takeaway for us is that with Rio committing $1.8 billion in financing for the project’s development and assuming management of the mine, the risk of owning Ivanhoe is reduced. With copper prices hitting record highs and likely headed higher still, we expect the stock to rebound shortly. And it will remain a takeover target for Rio or some other mining giant eager to tap into China’s voracious appetite for metals. Ivanhoe is also attractive for its 57 percent stake in SouthGobi Resources, a rapidly growing coal miner with Mongolian properties near China’s steel manufacturing heartland. Ivanhoe is a buy for new subscribers at its current price. Our Gabriel Resources (GBU.TO, GBRRF) trade continues to work out nicely. The stock ran to $8.60 last week before some profit taking set it. The stock has strength in gold going for it, as well as economic difficulties in Romania keeping pressure on the government to allow Gabriel to move forward with its mining project, which will be instrumental in creating jobs in the country’s most depressed region. In the latest development, the opposition Social Democratic and Liberal Parties have agreed to submit another no-confidence motion against Basescu’s center-right coalition government as the currency, the leu, remains under pressure and austerity measures have deepened the economy’s contraction. Gabriel’s stock is a buy for new subscribers. Read More
Buy Ivanhoe Mines (IVN) at the market price. Ivanhoe Mines (IVN) is sitting atop the world’s largest undeveloped copper deposit. That deposit, moreover, is situated in Mongolia, just a short train ride from the Chinese border, where nearly half of the world’s annual copper production is now consumed. … Read More
Stock investors largely took yesterday off it seems, with blue chip share prices little changed on the day and volume was quite light. The one bright spot was small caps, as the unweighted average of all stocks on the NYSE managed to gain six-tenths of a percent. Today, investors are buying stocks of all stripes in bulk. Read More
Gabriel Resources (GBU.TO, GBRRF) touched a new high the other day in response to the positive action in gold. Still, we rate the stock a buy for new investors as it offers tremendous upside pending the Romanian government’s seal of approval to move forward with its gold mining project there. Read More
The EU rode to Ireland’s rescue the other day, as expected, putting together an €85 billion ($113 billion) bailout package. The move, however, did little to dispel the belief that other countries, such as Portugal and Spain, will eventually need assistance before long as well. Read More
We made no changes since our last update. Amylin Pharmaceuticals (AMLN) continues to trade in a narrow range. We opted for an equity position with this trade rather than an option as we expected nailing the timing of the stock’s rebound might prove difficult. We are, however, confident the company will ultimately succeed in bringing the long-acting version of its diabetes drug to market, and the shares will rise considerably long in advance of Amylin getting the FDA’s seal of approval. The stock is a buy for new clients. Gold is moving higher, gaining renewed interest as a safe haven in times of trouble. This has helped power Gabriel Resources (GBU.TO, GBRRF) toward $8 a share level. As with Amylin, we’re prepared to hold this stock for an extended period. We’ve been well rewarded for our patience so far and think solid gains from here await us down the road. The stock is a buy for new investors. The Technology Select Sector SPRD ETF December 18, 2010 21 put option is a hold. Next regularly scheduled issue, Tuesday, December 7. RESULTS SINCE AGGRESSIVE TRADER’S INCEPTION AVERAGE GAIN PER CLOSED TRADE 4.0%, HOLDING PERIOD: 49 DAYS Read More
Last week it was China, this week it’s Europe that’s setting the tone it the markets, with a little help from the Korean Peninsula. After steadfastly denying for weeks that it needed support, the Irish government bowed to pressure and applied for bailout funds from the EU and IMF to… Read More
Salesforce.com (CRM) blew through expectations with its quarterly results last week, forcing us to abandon our Salesforce.com January 21, 2011 105 put option for a stiff loss. Amylin Pharmaceuticals (AMLN) continues to trade in a narrow range, below the technically important $13.50 resistance level. A close above that level would… Read More